ResearcherZhejiang Cancer HospitalActive in the last 2 years
Yaqun Zhu
Matched on ORCID iD 0000-0002-0952-7517; OpenAlex author ID A5050701259. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- Comparative efficacy of postoperative adjuvant chemoradiotherapy versus no chemoradiotherapy in the treatment of pancreatic adenocarcinoma. Co-author DOI 10.1186/s12885-026-16408-1↗
- Dihydrofolate Reductase (DHFR) Inhibition Promotes Ferroptotic Cell Death Through Nrf2 Suppression to Enhance Radiosensitivity In Pancreatic Ductal Adenocarcin… Co-author DOI 10.21203/rs.3.rs-3353533/v1↗
- (125)I particle implantation combined with chemoradiotherapy to treat advanced pancreatic cancer. Last author DOI 10.1259/bjr.20130641↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qiliang Peng · 2 shared papers, 2023–2026 · strength 0.46
- Paper Comparative efficacy of postoperative adjuvant chemoradiotherapy versus no chemoradiotherapy in the treatment of pancre… DOI 10.1186/s12885-026-16408-1↗
- Paper Dihydrofolate Reductase (DHFR) Inhibition Promotes Ferroptotic Cell Death Through Nrf2 Suppression to Enhance Radiosens… DOI 10.21203/rs.3.rs-3353533/v1↗
- Bixin Ren · 1 shared paper, 2026 · strength 0.29
- Jiao Xue · 1 shared paper, 2023 · strength 0.17
- Ying Gu · 1 shared paper, 2023 · strength 0.17
- Y-P Yu · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.